A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer

Tumor Biology - United States
doi 10.1177/1010428317702899
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

Pathological Response in a Triple Negative Breast Cancer Cohort Treated With Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Clinical Cancer Research
Cancer ResearchOncology
2018English

Pathological Complete Response After Neoadjuvant Chemotherapy With Trastuzumab-Containing Regimen in Gastric Cancer: A Case Report

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2010English

Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Hormone Receptor-Negative as a Predictive Factor for Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer

Einstein (São Paulo, Brazil)
Medicine
2019English

MicroRNA-143 Is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2019English

Conversion of Immunohistochemical Markers and Breast Density Are Associated With Pathological Response and Prognosis in Very Young Breast Cancer Patients Who Fail to Achieve a Pathological Complete Response After Neoadjuvant Chemotherapy

Cancer Management and Research
Oncology
2019English

Does Breast Conserving Therapy and Mastectomy Yield Similar Outcomes Following Neoadjuvant Chemotherapy With Pathological Complete Response?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy